Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

ADVERTISEMENT



almanac button

submit article ideas here

ADVERTISEMENT

PharmTech Poll
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
pharmtech's list of regulatory databases
Foss

Content Uniformity Made Easy

Metrics

Custom Engineered Potent Products Facility

ADVERTISEMENT

Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Last updated on Thu Jul 24 16:08:33 EDT 2014

Tabletting performance of sorbitol excipient
March 5, 2014
Binders in Tablet Manufacturing
July 7, 2010
Advertiser Gallery
Click here